How can pharma manage rising trial costs?

Clinical trial costs have been rising year-on-year, with companies working to balance the scales and keep studies running despite declining investment.

The pharma and biotech sector appeared to be jumping into action during the 2021 financial boom, however, this was followed by a drought of financing in the three years since. At the same time, costs have been rising for research, meaning companies who are yet to market a product are caught in the middle of a perfect storm.